Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS)
Abstract Introduction Approximately one-third of psoriasis cases present in the first two decades of life. Many psoriasis treatments are approved by the U.S. Food and Drug Administration (FDA) for adults, including topical agents, systemic non-biologic agents, and systemic biologic agents. Only a ha...
Saved in:
Main Authors: | Rachel E. Tao (Author), Jessica N. Pixley (Author), Phillip G. Holovach (Author), Alan B. Fleischer (Author), Steven R. Feldman (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toward the Next Generation of U.S. National Longitudinal Surveys
by: Adam Gamoran
Published: (2016) -
Sleep duration, baseline cardiovascular risk, inflammation and incident cardiovascular mortality in ambulatory U.S. Adults: National health and nutrition examination survey
by: Kartik Gupta, et al.
Published: (2021) -
When should systemic biologic therapy for psoriasis be discontinued?
by: Diem-Phuong D. Dao, et al.
Published: (2023) -
Racial differences in access to psoriasis biologics
by: Shirley P. Parraga, et al.
Published: (2024) -
Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database
by: Steven R. Feldman, et al.
Published: (2017)